NCT01428635 2023-09-26Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase TherapyM.D. Anderson Cancer CenterPhase 2/3 Completed21 enrolled 10 charts
NCT03303950 2022-05-05Allogeneic Stem Cell Transplantation for Multiple Myeloma and MyelofibrosisUniversity of UtahPhase 2 Terminated6 enrolled 17 charts
NCT03195010 2019-10-21Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced ThrombocytopeniaFred Hutchinson Cancer CenterPhase 2 Terminated4 enrolled 13 charts
NCT01165996 2019-03-04Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic SyndromeCase Comprehensive Cancer CenterPhase 1/2 Completed25 enrolled 13 charts
NCT02805868 2016-10-24Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia MyelofibrosisNorthwestern UniversityPhase EARLY_PHASE1 Withdrawn
NCT00493181 2012-02-20Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) PatientsM.D. Anderson Cancer CenterPhase 2 Completed8 enrolled 3 charts